Navigation Links
Sysmex America Receives FDA Clearance for XE-5000(TM) Hematology Analyzer
Date:12/11/2007

MUNDELEIN, Ill., Dec. 11 /PRNewswire/ -- Sysmex America, Inc. today announced that its Sysmex XE-5000 Automated Hematology Analyzer has been cleared by the United States Food and Drug Administration (FDA) for sale in the U.S. The XE-5000 represents an enhanced, best-in-class, high throughput analyzer that provides 31 whole blood reportable parameters including advanced clinical parameters and a body fluid specific mode. The Sysmex XE-5000 will be available in the United States, in Latin America and in Canada beginning in December 2007.

Like its other X-Series counterparts, the XE-5000 uses Sysmex's patented fluorescent flow cytometry technology, providing both routine hematology testing and abnormal cell flagging within a single sample run. The body fluid specific mode is the first of its kind in the industry with reportable body fluid differential parameters for all common body fluids (CSF, Serous and Synovial). Complete information within a single analysis reduces manual intervention and the errors inherent in manual counts. Hospital or university laboratories and clinics with renal, oncology and acute care patient populations will benefit from the XE-5000.

"The XE-5000 is Sysmex's next step in aiding our nation's larger-volume clinical laboratories in their efforts to become increasingly efficient with their staffing and financial resources without sacrificing quality or accuracy. With the proven reliability of Sysmex analyzers, clinical laboratories have the assurance of greater uptime," said John Kershaw, president, Sysmex America, Inc.

As with other Sysmex product lines, the XE-5000's performance can be remotely monitored by SNCS(TM) (Sysmex Network Communications Systems). SNCS continuously collects and monitors hundreds of real-time performance codes from Sysmex analyzers. This feature generates a technical review of any potential critical instrument errors that may be occurring behind the scenes. The connectivity allows Sysmex te
'/>"/>

SOURCE Sysmex America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Sysmex America Awarded Hematology Contract by Amerinet
2. Many Older Americans Have Active Sex Lives
3. Despite grumbling, most Americans say they are happy at work
4. Record Number of Americans Lack Health Insurance
5. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
6. Campaign for Americas Future Memorandum: Katrina Storm Warning
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
9. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
10. Novo Nordisk Appoints New Leader of North American Business
11. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Anthony J. Tantillo, Esq., Attorney ... for his third consecutive year in a row. Through nomination, research and strategic ... , Born in Niagara Falls, New York, Tantillo is a Buffalo State College graduate ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, ... safety labels and stickers to keep little ones' safety top of mind at all ... has a particular focus. According to the JPMA's Baby Safety Zone website, this year's ...
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs for ... of new premium on-demand video Evidence Based Practice courses that ... 2014 must complete 50 CEUs before December 31, 2015, which must include at ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Sculpted Contours Luxury ... Atlanta’s Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. ... business as well as Kathy King. Her idea and vision to bring to ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Southern Vacation Rentals ... has teamed up with fellow South Walton property management company, 360 Blue, ... poverty in remote parts of the world. The two companies will collect any unopened ...
Breaking Medicine News(10 mins):Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3
... Md., Nov. 29 ,Micromet, Inc. (Nasdaq: MITI ) ... ongoing Phase 1 clinical trial of MT103 in patients ... the 2007 Annual,Meeting of the American Society of Hematology ... as MEDI-538, is a recombinant T-cell,engaging antibody, or BiTE(R) ...
... Such as Tenet and Kaiser, SUNNYVALE, ... announced it signed a group purchasing contract ... serving more than 20,000 acute care,hospitals, ambulatory ... throughout the United States. Under the terms ...
... Release Following Extension of Service Offering ... CEVA Third Quarter 2007 Results, HOOFDDORP, The ... Interim Financial Statements today. These,statements include the following highlights:, - ... - EBITDA increased to EUR86.9 million from EUR(4.3) million in ...
... HILLS, Calif., Nov. 29 CalbaTech, Inc.,(OTC ... company,( http://www.CalbaTech.com ) concentrating on the collection ... future therapeutic uses and providing,products and platforms ... to academic institutions, is pleased to announced ...
... New Report from the American Legacy Foundation(R) Finds ... 29 America,s Medicaid,system could spend nearly $10 ... who smoke, quit. A new study released today ... prevention and,cessation programs could cut Medicaid costs by ...
... the U.S. is caused by a form of bacteria, ... It typically begins with a bulls-eye skin rash, ... If diagnosed early, Lyme can be treated successfully ... Nearly 60 percent of patients who do not ...
Cached Medicine News:Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 3Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 4Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 5Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 6Health News:Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA 2Health News:Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA 3Health News:Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA 4Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 2Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 3Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 4Health News:CalbaTech Reports That LifeStem's Biologics License Has Been Renewed 2Health News:CalbaTech Reports That LifeStem's Biologics License Has Been Renewed 3Health News:Smokers Cost Medicaid System Nearly $10 Billion 2Health News:Smokers Cost Medicaid System Nearly $10 Billion 3Health News:Antibody responses in patients with Lyme arthritis 2Health News:Antibody responses in patients with Lyme arthritis 3
(Date:8/31/2015)... -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a late-stage ... Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical ... investor conferences in September. , ... LLC Emerging Growth Conference in New ... President & Chief Executive Officer, will present a corporate ...
(Date:8/31/2015)... , August 31, 2015 ... BOLT, OTCQX: BLGTY) ("BioLight" or the "Company"), a ... innovations in ophthalmology and cancer diagnostics, today announced ... MCTC), has identified several new genetic markers with ... in patients treated with bisphosphonate drugs and was ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... Calif., Oct. 7 Onyx Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) filing for carfilzomib based ... Controls (CMC) review division of the U.S. Food and ... information related to commercial-scale manufacturing of carfilzomib.  Onyx had ...
... NEW YORK, Oct. 7 Reportlinker.com announces that a ... European RIS/PACS Market ... European RIS/PACS market in terms of the challenges faced ... The main chapters of the research service include an ...
Cached Medicine Technology:Onyx Pharmaceuticals Provides Status Update on Carfilzomib 2Onyx Pharmaceuticals Provides Status Update on Carfilzomib 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
Alcon offers medical grade perfluoropropane (C3F8) intraocular gases for ophthalmological use....
Round knurled handle. Overall length 130 mm....
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
5 inch (12.7 cm), 2 x 5 mm blade....
Medicine Products: